Division of Stem Cells and Regenerative Medicine, Biomedical Postgraduate Programme, School of Medicine, University of Patras, Patras 26504, Greece; Department of Physiology, School of Medicine, University of Patras, Patras 26504, Greece.
Division of Stem Cells and Regenerative Medicine, Biomedical Postgraduate Programme, School of Medicine, University of Patras, Patras 26504, Greece.
Adv Drug Deliv Rev. 2018 Apr;129:242-253. doi: 10.1016/j.addr.2018.02.007. Epub 2018 Mar 1.
Wound healing response plays a central part in chronic inflammation, affecting millions of people worldwide. It is a dynamic process that can lead to fibrosis, if tissue damage is irreversible and wound resolution is not attained. It is clear that there is a tight interconnection among wound healing, fibrosis and a variety of chronic disease conditions, demonstrating the heterogeneity of this pathology. Based on our further understanding of the cellular and molecular mechanisms underpinning tissue repair, new therapeutic approaches have recently been developed that target different aspects of the wound healing process and fibrosis. Nevertheless, several issues still need to be taken into consideration when designing modern wound healing drug delivery formulations. In this review, we highlight novel pharmacological agents that hold promise for targeting wound repair and fibrosis. We also focus on drug-delivery systems that may enhance current and future therapies.
创伤愈合反应在慢性炎症中起着核心作用,影响着全球数百万人。这是一个动态的过程,如果组织损伤是不可逆转的,并且伤口没有得到解决,可能会导致纤维化。显然,创伤愈合、纤维化和各种慢性疾病之间存在着紧密的相互联系,这表明这种病理学具有异质性。基于我们对组织修复的细胞和分子机制的进一步理解,最近已经开发出了新的治疗方法,这些方法针对创伤愈合过程和纤维化的不同方面。然而,在设计现代创伤愈合药物输送制剂时,仍需要考虑几个问题。在这篇综述中,我们重点介绍了一些有希望用于靶向创伤修复和纤维化的新型药理学制剂。我们还关注了可能增强现有和未来疗法的药物输送系统。